Hostile Is No Longer a Slur: METI's 2023 Guidelines for Corporate Takeovers

TL;DR - METI's 31 August 2023 Guidelines for Corporate Takeovers replaced the 2005 defence-friendly framework with three operative principles — corporate value, shareholder intent, transparency — and introduced the "bona-fide offer" doctrine: boards must engage with a genuine proposal, not reflexively reject it. - The Guidelines coincided with and catalysed a wave of mega-MBOs: Toshiba (JPY ~2 trn, JIP, Sep 2023), Benesse (JPY 208 bn, EQT/Fukutake, Feb 2024), Taisho Pharmaceutical (JPY 710 bn, Uehara MBO, Nov 2023), Outsourcing (Bain, Dec 2023), and Blackstone's Infocom carve-out (Nov 2024). - The 2024 FIEA amendments — Diet-passed May 2024, effective 1 May 2026 — lowered the mandatory-TOB threshold from >1/3 to >30% and brought on-market purchases into TOB scope. METI's Fair Acquisition Study Group was reconvened on 3 February 2026 to update guidance on hostile-takeover countermeasures and preconditional TOBs.

A 2005-doctrine reversal

For roughly fifteen years, the Japanese discourse on hostile takeovers ran on a doctrine quietly embedded in METI's 2005 Guidelines on Takeover Defences (the so-called baishu boueisaku shishin). The 2005 guidelines were issued in the wake of the Steel Partners–Bull-Dog Sauce and Murakami Fund–Hanshin Electric Railway episodes; their language was carefully neutral on paper but in practice gave Japanese boards substantial latitude to deploy poison-pill defences and to characterise hostile bids as inherently suspect. The default cultural framing — that hostile was a slur — survived for the same period.

The 2023 reversal is doctrinal, not merely linguistic. METI's Guidelines for Corporate Takeovers (企業買収における行動指針), published 31 August 2023 after the Fair Acquisition Study Group convened in November 2022, replaces the 2005 framing with three principles whose ordering matters:

Corporate Value and Shareholders' Common Interest. A takeover proposal should be evaluated by reference to its expected contribution to corporate value and the common interest of shareholders.
Shareholder Intent. Shareholders should have sufficient information and time to evaluate a proposal and express their intent.
Transparency. The target board's process and reasoning should be disclosed transparently.

The structural innovation is the first principle's elevation of shareholder common interest over board judgement of corporate value. The 2005 framework asked, in effect, "does the board believe this offer is good for the company?" The 2023 framework asks, "is this offer good for shareholders, judged in a process that gives them a fair say?" The difference is the entire policy reversal.

A consequence of the reformulation is the introduction of the "bona-fide offer" (真摯な買収提案) doctrine: where a credible third party makes a genuine proposal — defined by its substantive seriousness, not by its friendliness — the target board has an affirmative duty to engage. Reflexive rejection, foot-dragging, or use of structural defences to deny shareholders the chance to consider the offer are now characterised as breaches of the board's duty to shareholders' common interest.

What "bona-fide" actually means

The Guidelines do not specify a numerical or procedural threshold for an offer to qualify as bona-fide. Three indicia are described instead:

Credibility of the proponent. A proposer who is a recognised financial or strategic acquirer with the financial capacity to execute.
Substantive seriousness. A proposal that includes price, structure, financing and a plausible operational thesis — not merely a non-binding "indication of interest."
Constructive intent. Willingness of the proposer to engage in dialogue, provide additional information, and respond to the board's concerns.

The threshold is purposely qualitative. In practice, it has been operationalised by Japanese boards through a five-step playbook: receive the proposal; convene the special committee within a defined window (often 10 business days); request supplementary information; conduct a market check; and produce a transparent board response that explains the engagement process.

The takeover-process timeline

timeline
    title Japanese Takeover Process Under the 2023 Guidelines
    Bona-fide offer received : Letter / NDA / preliminary terms
                              : Board acknowledges receipt within ~5-10 business days
    Special committee formed : Independent directors + external advisers
                            : Mandate, scope, operating rules disclosed
    Engagement phase : Information exchange under NDA
                    : Special-committee due diligence
                    : Independent valuation work
    Market check : Optional dual-track / go-shop
                : Outreach to alternative bidders
    Board response : Recommendation or rejection
                  : Disclosure of reasoning
                  : Disclosure of special-committee opinion
    Tender offer launch : Statutory TOB under FIEA
                       : Tender period (20-60 business days)
                       : Squeeze-out completion

Each step in the timeline is now expected to be disclosed under Principle 3 of the Guidelines. The disclosure obligations have produced a recognisable house style in 2024-25 Japanese takeover documentation: a long, prose-heavy board statement that walks shareholders through the proposal, the special-committee composition, the engagement timeline, the market-check process, the valuation work, and the recommendation. The Toshiba, Benesse, Taisho and Outsourcing documents are good worked examples.

The five case studies that made the Guidelines real

Toshiba (JIP-led, September 2023, JPY ~2 trn)

The Toshiba take-private is the largest Japanese take-private on record and the first major test of the new doctrine. The Japan Industrial Partners (JIP) led consortium, supported by Orix and Chubu Electric, completed the tender at JPY 4,620/share. The transaction ended Toshiba's 74-year listing and resolved a years-long activist saga (Effissimo, Elliott, 3D Investment, Farallon).

What made Toshiba a Guidelines case is the process discipline the board imposed after years of internal turmoil. A special committee of independent directors ran the bid solicitation, reviewed competing proposals from JIP, KKR, Bain and CVC, conducted explicit market-check work, and disclosed the rationale for the eventual JIP selection. The Toshiba process is now the de facto reference for any going-private transaction north of JPY 500 bn — and the precedent every subsequent Japanese mega-MBO has cited.

Benesse Holdings (EQT/Fukutake family, February 2024, JPY 208 bn)

The Benesse Holdings MBO is the cleanest controlled-company case to apply the 2019 Fair M&A Guidelines / 2023 Takeover Guidelines architecture in full. The Fukutake family (founders, holding ~50%) partnered with EQT to take the company private at JPY 2,600/share — a 45.13% premium to the unaffected price. Total deal value JPY 208 bn (announced November 2023; closed February 2024).

What makes Benesse instructive is the MBO conflict architecture. With founder management on the buying side, the special-committee + majority-of-minority + market-check triad becomes load-bearing for fairness. Benesse's special committee included two independent directors and two outside advisers; the majority-of-minority condition required acceptance by holders of more than 50% of the non-Fukutake float; and a market check identified two alternative parties before EQT was selected. The 45% premium, although the median for Japanese MBOs, was defended by the special committee in a published opinion.

Taisho Pharmaceutical Holdings (Uehara family MBO, November 2023, JPY 710 bn)

The Taisho Pharmaceutical MBO priced at JPY 8,620/share, a 50% premium to the 6-month average, total deal value JPY 710 bn. It was the largest family-MBO in Japanese history at announcement and the second-largest controlled-company transaction of 2023 after Toshiba.

The case is significant because it generated a price-fairness debate. Several minority shareholders argued that the 50% premium understated intrinsic value because Taisho's brand and franchise (Lipovitan, OTC dominance) carried significant non-disclosed earning power. The Uehara family's response — that the premium fairly compensated minority shareholders given the long-run business risks — was accepted by the special committee but received pushback from foreign-investor representatives. Taisho is now cited as the case that demonstrates family-MBO premiums require especially explicit valuation reasoning under the Guidelines.

Outsourcing Inc. (Bain Capital, December 2023)

The Outsourcing Inc. take-private by Bain Capital was notable for two features. First, the price increased twice during the offer period (from JPY 1,755 to JPY 2,094) in response to a competing bid by Bain itself in a so-called "white knight" sequence — a process that demonstrated competitive tension can be engineered within the new Guidelines' framework. Second, the special committee's process was reviewed positively by ACGA as an early demonstration of how an independent-led process can deliver an improved price for minorities.

Infocom (Blackstone, November 2024, JPY 287 bn)

The Infocom carve-out by Blackstone was the first major parent-driven sale under the new Guidelines. Teijin sold its 55% stake in Infocom to Blackstone at JPY 6,060/share. The transaction was structured as a competitive process with multiple bidders, with the controlling-parent (Teijin) sale running in parallel with a TOB for the minority float. The structure resolves the listed-subsidiary conflict (post-deal Infocom is no longer a Teijin subsidiary) and provides minority shareholders an exit at a defined premium.

Infocom is now cited as the template for parent-driven divestitures of listed subsidiaries — a pattern likely to recur across the trading-house, electronics and IT-services sectors over 2026-27.

The 2024 FIEA amendments

A frequent IR-team confusion is to conflate the 2023 Takeover Guidelines (soft law, METI, doctrine) with the 2024 FIEA amendments (hard law, FSA, mechanics). The two are distinct but mutually reinforcing.

The 2024 FIEA amendments were passed by the Diet in May 2024 and the corresponding Cabinet Office Ordinance was finalised on 4 July 2025, with the operative changes effective from 1 May 2026. Two changes matter most:

The mandatory-TOB threshold drops from >1/3 to >30%. Any purchaser who, alone or with joint holders, acquires more than 30% of a listed company's voting rights now triggers the mandatory tender offer obligation. The previous threshold of 1/3 had been criticised as exploitable through structured "below-threshold" acquisitions that captured de facto control without triggering the equal-treatment obligation.

On-market purchases now fall within TOB scope. Previously, on-market open-market purchases were exempt from the TOB regime, creating an avenue for accumulation outside the equal-treatment principle. Under the amendments, on-market purchases above the 30% threshold are within scope.

The combined effect is to tighten the equal-treatment principle: any acquisition pathway that takes voting power above 30% now has to be conducted as a TOB, regardless of structure. This is a structural shift in the M&A regulatory regime that will reshape how raiders, activists and strategic acquirers approach Japanese targets.

A related amendment — the clarification of "joint holders" and "acts of material proposal" — narrows the 5%-rule trigger in ways that should reduce the chilling effect on collaborative engagement (see Post 5.7). The two amendments together represent a coordinated rewiring of the FIEA disclosure and TOB framework.

The February 2026 reconvening

METI's Fair Acquisition Study Group was reconvened on 3 February 2026 to update the 2023 Guidelines on two topics:

Hostile-takeover countermeasures. The 2023 Guidelines did not prescribe a specific stance on poison pills, white-knight defences or other structural countermeasures. The reconvened Study Group is expected to provide more detailed guidance on when countermeasures are consistent with the bona-fide-offer doctrine and when they cross into improper defence territory.
Preconditional TOBs. Several recent transactions have included pre-conditions to the TOB launch — such as regulatory clearance, financing certainty, or due-diligence completion — that effectively suspend the tender. The Study Group is expected to provide guidance on the consistency of such preconditions with the shareholder-intent principle.

Both items reflect the operational refinement that the 2023 Guidelines now require. The doctrine is settled; the implementation questions are not.

The new doctrine in practice — three observations

One — the volume effect. Public-M&A deal count rose around 15% YoY in 2023 and again in 2024, with going-private activity setting records. The Toshiba, Benesse, Taisho, Outsourcing and Infocom transactions are not isolated events; they are the visible peaks of a structural shift in how Japanese boards engage with acquisition proposals. The Guidelines did not create the demand for deals — that was largely driven by the cost-of-capital revolution (Theme 4) and by financial-sponsor capital availability — but they removed institutional friction that had previously suppressed conversion of demand into transactions.

Two — the premium standard. The 2024-25 Japanese take-private universe shows a relatively narrow premium range — most deals between 40-50% to the unaffected price. This is a meaningfully higher central tendency than the 2010s norm (~25-30%). The Guidelines' shareholder-intent principle has effectively re-anchored the premium-fairness conversation around the 40% mark.

Three — the activist effect. The Guidelines created an institutional pathway through which activists can credibly threaten — and credibly execute — engagement with controlled and family-controlled targets. Elliott's intervention in Toyota Industries, ValueAct's positions in Seven & i and JSR, and the multiple activist positions visible in Toshiba's pre-take-private saga are all examples. The doctrine works both ways: activists can use it to demand price increases, and managements can use it to argue for engagement with proposals that minority shareholders demand they consider.

What this means for IR

Build a standing takeover-response playbook. Even if your company has no current acquisition exposure, the board should have a documented process for receiving and evaluating a bona-fide offer. Three elements at minimum: special-committee composition, advisor engagement protocols, and disclosure templates.
Treat "reflexive rejection" as out of bounds. The Guidelines explicitly characterise reflexive rejection of a bona-fide offer as a potential breach of the board's duty. Train senior management and IR teams to acknowledge receipt promptly, engage the special-committee mechanism, and avoid early defensive public statements.
Document your independent-director independence — from the controlling shareholder, if any. In controlled-company contexts, the special committee's effectiveness depends on directors who are demonstrably independent of the controlling party. This is a documentation discipline as much as a selection discipline.
Brief your major shareholders on the bona-fide-offer doctrine. Many domestic institutional investors and corporate cross-holders still operate on the 2005 mental model. An IR team that pre-emptively explains how the board would respond to a bona-fide offer — and what shareholders' role in that process is — pre-empts confusion if a proposal arrives.
Monitor the February 2026 reconvening output. The reconvened Fair Acquisition Study Group will publish guidance over 2026 on countermeasures and preconditional TOBs. Both items have implications for IR teams; both should be reviewed when published and reflected in the takeover playbook.

Sources & further reading

METI press release, "METI Formulates Guidelines for Corporate Takeovers" (31 August 2023): https://www.meti.go.jp/english/press/2023/0831_001.html
METI, "Guidelines for Corporate Takeovers" (English reference translation, PDF): https://www.meti.go.jp/english/press/2023/pdf/0831_001b.pdf
METI, "Reconvening of Fair Acquisition Study Group" (February 2026): https://www.meti.go.jp/english/press/2026/0203_001.html
METI, "Fair M&A Guidelines" (2019, English): https://www.meti.go.jp/policy/economy/keiei_innovation/keizaihousei/pdf/fairmaguidelines_english.pdf
DLA Piper, "Recent developments on TOB rules and shareholding transparency in Japan" (January 2026): https://www.dlapiper.com/en/insights/publications/2026/01/recent-developments-on-tob-rules-and-shareholding-transparency-in-japan
FSA, "Action Programme for Corporate Governance Reform 2025": https://www.fsa.go.jp/en/news/2025/20250630-1.html

Next in this theme: 5.5 SSBJ in Action: the three-phase sustainability disclosure roll-out